The AKT and mechanistic target of rapamycin (mTOR) pathways, which promote
Chemexpress The AKT and mechanistic target of rapamycin (mTOR) pathways, which market survival and growth and are upregulated in a lot of cancers. Importantly, sirolimus, an inhibitor of mTOR, can treat…